v3.26.1
Common Stock and Warrants (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 29, 2026
Apr. 28, 2026
Apr. 10, 2026
Jan. 22, 2026
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock, shares authorized         100,000,000       100,000,000   100,000,000
Common stock, shares, issued         12,468,059       12,468,059   10,652,812
Common stock, shares, outstanding         12,468,059       12,468,059   10,652,812
Consulting and advisory fees                 $ 399,995 $ 112,493  
General and administrative expense         $ 2,645,103   $ 1,816,091   4,851,395 4,260,246  
Prepaids and other current assets         $ 381,654       $ 381,654   $ 315,283
Common stock, par value         $ 0.001       $ 0.001   $ 0.001
Cumulative dividend rate   8.50% 8.50%                
Proceeds from common stock                 $ 5,061,018 4,999,999  
Proceeds from warrant exercise                 943,970 1,002,991  
Stock issued period warrant exercised         $ 436,935 $ 507,035 1,002,991      
Board of Directors Chairman [Member] | Series B Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock, par value     $ 0.001                
December 31, 2026 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Consulting and advisory fees       $ 199,995              
General and administrative expense         50,000       100,000    
Prepaids and other current assets         $ 99,995       $ 99,995    
December 31, 2025 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Consulting and advisory fees       $ 200,000              
General and administrative expense             $ 50,000     $ 100,000  
Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock issued during period , shares 80,456 510,605 510,605     86,392   39,471   39,471  
Number of shares exercised                 396,626 720,359  
Stock issued upon conversion             384,032   29,828 384,032  
Common stock warrant, exercised         183,586 213,040 720,359 186,166   186,166  
Share based compensation warrant exercised                 396,626 502,647 1,263,006
Stock issued period warrant exercised         $ 184 $ 213 $ 720 $ 186   $ 186  
Common Stock [Member] | Securities Purchase Agreement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock issued during period , shares                   1,538,461  
Common Stock [Member] | Employee Stock Purchase Plan [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock issued during period , shares                 43,885    
Proceeds from common stock                 $ 86,015    
Common Stock [Member] | Investor [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock issued during period , shares                 747,911    
Proceeds from common stock                 $ 5,061,018    
Common Stock [Member] | December 31, 2026 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock issued during period , shares       43,196              
Common Stock [Member] | December 31, 2025 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock issued during period , shares       43,196